Phong Phu Pharmaceutical JSC (HNX:PPP)

Market Cap	181.28B +15.7%
Revenue (ttm)	139.83B +1.7%
Net Income	18.55B +6.9%
EPS	1,884.00 +6.6%
Shares Out	8.80M
PE Ratio	10.93
Forward PE	n/a
Dividend	1,500.00 (7.28%)
Ex-Dividend Date	Mar 19, 2026

Volume	828
Average Volume	828
Open	20,300
Previous Close	20,600
Day's Range	20,300 - 20,600
52-Week Range	17,200 - 23,100
Beta	0.04
RSI	58.25
Earnings Date	Jan 23, 2026

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. Phon...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 212
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PPP

Financial Performance

In 2025, HNX:PPP's revenue was 139.83 billion, an increase of 1.66% compared to the previous year's 137.55 billion. Earnings were 18.55 billion, an increase of 19.34%.